Savient Pharmaceuticals Rising On Takeover Rumor (SVNT) - Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN)

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Shares of Savient Pharmaceuticals Inc (NASDAQ: SVNT) just popped on rumors it could be the subject of a takeover rumor.At this time, it is not known who the potential acquirer could be, but a Reuters article posted yesterday indicated that Abbott (NYSE: ABT), Pfizer (NYSE: PFE) or Amgen (NASDAQ: AMGN) could be potential suitors.Shares of SVNT are up 58 cents to $20.86, a gain of 2.86%.Savient is a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States.

20-Year Pro Trader Reveals His "MoneyLine"

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!